|
2025
|
P/S
|
Medicines for the modification of genes and treatment of diseases, for use in the treatment of re... |
|
|
Invention
|
Lipid nanoparticles for extrahepatic delivery. Provided herein are lipid nanoparticles compositio... |
|
|
Invention
|
Lipid nanoparticles for hepatic delivery. Provided herein are lipid nanoparticles composition com... |
|
|
Invention
|
Lipid nanoparticle compositions and uses thereof.
Provided are aerosolized pharmaceutical compos... |
|
|
Invention
|
Systems and methods for generating lipid nanoparticles. The present disclosure provides systems a... |
|
2024
|
Invention
|
Polynucleotide compositions, related formulations, and methods of use thereof.
Compositions of p... |
|
|
Invention
|
Gene editing methods and compositions for treating cystic fibrosis. Provided are methods to treat... |
|
|
Invention
|
Lipid nanoparticle compositions and uses thereof and method for quantifying an amount of capped m... |
|
|
Invention
|
Lipid nanoparticle compositions and uses thereof. Disclosed herein are lipid nanoparticles (LNPS)... |
|
|
Invention
|
Lipid nanoparticle compositions and uses thereof. Provided are aerosolized pharmaceutical composi... |
|
|
Invention
|
Lipid nanoparticle compositions and uses thereof. Provided are methods for delivering lipid nanop... |
|
|
Invention
|
Compositions and methods for targeted delivery to cells.
Described herein are compositions, kits... |
|
|
Invention
|
Method for quantifying an amount of capped messenger rna. Provided are a method for quantifying a... |
|
|
Invention
|
Polynucleotide compositions, related formulations, and methods of use thereof. Compositions of po... |
|
2023
|
Invention
|
Compositions and methods for targeted delivery to cells. Described herein are compositions, kits,... |
|
2022
|
Invention
|
Compositions, methods and uses for treating cystic fibrosis and related disorders.
Described her... |
|
|
Invention
|
Compositions, methods and uses for treating cystic fibrosis and related disorders. Described here... |
|
|
Invention
|
Compositions and methods for targeted systemic delivery to cells. Described herein are compositio... |
|
2021
|
P/S
|
Medicines for the modification of genes and treatment of diseases; cell and gene therapy products... |
